- Latest week
- 10 Jul 2026
- Close
- 0.023000
- Fair value
- 0.038689
- Next-week expectancy
- Negative 37.78%
SNT Chart Pack
Syntara Limited
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, SNT fell 28.12%, moving from 0.03 to 0.02. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -27.58 and has softened across the 12-week window. Market Dynamics is -0.64 on the latest week. Next-week expectancy is negative at 37.78% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 0.02
- 12-Week Change
- -28.12%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 37.78%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Relative Strength
- -27.58
- Market Dynamics
- -0.64
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 0.02
- 12-Week Change
- -28.12%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 37.78%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Below
- Relative Strength
- -27.58
- Market Dynamics
- -0.64
Over the latest 12 completed weeks ending 2026-07-10, SNT fell 28.12%, moving from 0.03 to 0.02. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -27.58 and has softened across the 12-week window. Market Dynamics is -0.64 on the latest week. Next-week expectancy is negative at 37.78% based on similar historical setup states.
Industry Peers
Australia equities in Drug Manufacturers - Specialty & Generic
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| RGT Argent BioPharma Limited | ASX | 10 Jul 2026 | 0.04 | 0.11 | 0.04 | 0.07 | 105.71% |
| IVX Invion Limited | ASX | 10 Jul 2026 | 0.03 | 0.04 | 0.03 | 0.04 | 15.62% |
| LGP Little Green Pharma Ltd | ASX | 10 Jul 2026 | 0.07 | 0.07 | 0.07 | 0.07 | 4.48% |
| IDT IDT Australia Limited | ASX | 10 Jul 2026 | 0.03 | 0.03 | 0.03 | 0.03 | 3.23% |
| AFP AFT Pharmaceuticals Limited | ASX | 10 Jul 2026 | 3.04 | 3.30 | 3.04 | 3.13 | 2.96% |
| VLS Vita Life Sciences Limited | ASX | 10 Jul 2026 | 2.48 | 2.50 | 2.40 | 2.50 | 0.81% |
| BP8 BPH Global Ltd | ASX | 10 Jul 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
| ECS ECS Botanics Holdings Ltd | ASX | 10 Jul 2026 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00% |
| EPN Epsilon Healthcare Limited | ASX | 10 Jul 2026 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00% |
| EXL Elixinol Wellness Limited | ASX | 10 Jul 2026 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00% |
| PER PERCHERON FPO [PER] | ASX | 10 Jul 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
| VIT Vitura Health Limited | ASX | 10 Jul 2026 | 0.03 | 0.03 | 0.03 | 0.03 | 0.00% |
| MVP Medical Developments International Limited | ASX | 10 Jul 2026 | 0.42 | 0.44 | 0.41 | 0.41 | -2.41% |
| PKP PEAK FPO [PKP] | ASX | 10 Jul 2026 | 0.02 | 0.02 | 0.02 | 0.02 | -5.56% |
| CAN Cann Group Limited | ASX | 10 Jul 2026 | 0.01 | 0.01 | 0.00 | 0.00 | -10.00% |